Circe Biomedical, Inc. develops, produces, and commercializes bioartificial organ systems. It develops bioartificial organs from isolated mammalian cells and membranes for patients suffering from acute, end-stage liver failure. The company also develops PancreAssist System, an implantable, bioartificial pancreas for severe insulin-dependent diabetics. Circe Biomedical, Inc. was incorporated in 1999 and is based in Lexington, Massachusetts.
| Website | http://www.circebio.com |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 1999 |
| Address | 99 Hayden St, Lexington, Massachusetts 02421, US |
| Phone | +1 781-863-8720 |
| Industry | Biotechnology, Manufacturing General, Medical Supplies, Manufacturing, Science and Engineering, Health Care, Medical |
| Competitors | Moderna Therapeutics, bluebird bio, CureVac, Zymeworks Inc., Precision BioSciences, Inc., Celyad Oncology, Celsion Corporation, Glycostem Therapeutics, CureMatch, Inc., NantCell +42 more (view full list) |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Circe Biomedical employee's phone or email?
Circe Biomedical Questions
The Circe Biomedical annual revenue was $5 million in 2026.
Circe Biomedical is based in Lexington, Massachusetts.
The NAICS codes for Circe Biomedical are [54, 541].
The SIC codes for Circe Biomedical are [38, 384].
